PIGB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.189400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.119800E-01
Normal-vs-Stage2
3.450000E-01
Normal-vs-Stage3
2.031600E-01
Normal-vs-Stage4
3.788800E-01
Stage1-vs-Stage2
7.532200E-01
Stage1-vs-Stage3
1.843250E-01
Stage1-vs-Stage4
5.760200E-01
Stage2-vs-Stage3
2.454400E-01
Stage2-vs-Stage4
8.000800E-01
Stage3-vs-Stage4
4.382800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.607600E-01
Normal-vs-AfricanAmerican
1.632410E-01
Normal-vs-Asian
1.730430E-01
Caucasian-vs-AfricanAmerican
4.434800E-01
Caucasian-vs-Asian
9.885700E-02
AfricanAmerican-vs-Asian
6.745600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.248000E-01
Normal-vs-Female
3.168400E-01
Male-vs-Female
5.871400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.914400E-01
Normal-vs-Age(41-60Yrs)
2.718000E-01
Normal-vs-Age(61-80Yrs)
3.216200E-01
Normal-vs-Age(81-100Yrs)
6.720600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.261600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.596000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.496000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.512000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.542400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.840000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.748800E-01
Normal-vs-Daily Drinker
3.101600E-01
Normal-vs-Weekly Drinker
4.473800E-01
Normal-vs-Occasional Drinker
1.709410E-01
Normal-vs-Social Drinker
2.975800E-01
Non Drinker-vs-Daily Drinker
8.833400E-01
Non Drinker-vs-Weekly Drinker
9.657200E-01
Non Drinker-vs-Occasional Drinker
8.778000E-01
Non Drinker-vs-Social Drinker
9.049600E-01
Daily Drinker-vs-Weekly Drinker
9.487600E-01
Daily Drinker-vs-Occasional Drinker
9.955000E-01
Daily Drinker-vs-Social Drinker
9.880200E-01
Weekly Drinker-vs-Occasional Drinker
9.515400E-01
Weekly Drinker-vs-Social Drinker
9.618800E-01
Occasional Drinker-vs-Social Drinker
9.904000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.873600E-02
Normal-vs-Grade 2
1.318030E-03
Normal-vs-Grade 3
8.843800E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.554750E-01
Grade 1-vs-Grade 3
1.837220E-01
Grade 1-vs-Grade 4
5.873600E-02
Grade 2-vs-Grade 3
9.772000E-01
Grade 2-vs-Grade 4
1.318030E-03
Grade 3-vs-Grade 4
8.843800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.547600E-01
Normal-vs-NonDiabetic
3.397400E-01
Diabetic-vs-NonDiabetic
2.890000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.498800E-01
Normal-vs-NoPancreatitis
2.884400E-01
Pancreatitis-vs-NoPancreatitis
2.145800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.811600E-01
Normal-vs-N1
3.675800E-01
N0-vs-N1
9.200000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.253800E-01
Normal-vs-TP53-NonMutant
5.637600E-01
TP53-Mutant-vs-TP53-NonMutant
2.130600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
